Monitor the company's upcoming 10-Q for any guidance or financial updates, as this proxy filing contains no new financial information. The vote on executive compensation could be a minor read-through for investor sentiment if there is a significant 'say on pay' dissent, but none is indicated here.
Price Chart
Executive Summary
Edgewise Therapeutics is holding its 2026 Annual Meeting where shareholders are asked to vote on three proposals: electing three director nominees, ratifying KPMG LLP as the independent auditor, and approving the compensation of named executive officers. The filing is a definitive proxy statement filed by the company, indicating standard, routine corporate governance matters.
Key Facts
- The filing is a DEFA14A, a definitive proxy statement for the 2026 Annual Meeting.
- Three proposals are on the ballot: election of directors (Laura Brege, Badreddin Edris, Jonathan Root), ratification of KPMG LLP as auditors, and an advisory vote on executive compensation.
- The company is requesting votes by June 3, 2026, for a meeting on June 4, 2026.
- The filing was made by the registrant (Edgewise Therapeutics, Inc.), not a dissident party.
Financial Impact
No immediate financial impact. This is a routine governance filing.
Risk Factors
- Low. The primary risk is a potential 'say on pay' vote failure, which could signal governance concerns, but this is not indicated in the current filing.
- The routine nature of the proposals means there is minimal risk to the company's operations or stock price from this event.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-047691 |
| Document: 0001104659-26-047691-index-headers.html | 0001104659-26-047691 |
| Document: 0001104659-26-047691-index.html | 0001104659-26-047691 |
| Document: 0001104659-26-047691.txt | 0001104659-26-047691 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Insider Cluster | $44.17 $44.62 | ▲ +1.02% | ▲ +3.01% | $41.22 (−6.68%) |
Aug 14, 2026 7w ago | Insider Cluster | $44.17 $44.62 | ▲ +1.02% | ▲ +3.01% | $41.22 (−6.68%) |
Aug 6, 2026 8w ago | 8-K | $44.42 $41.95 | ▼ −5.56% | ▼ −6.16% | $41.22 (−7.20%) |
Jul 13, 2026 11w ago | 8-K | $41.27 $44.58 | ▲ +8.02% | ▲ +4.84% | $41.22 (−0.12%) |
Jun 1, 2026 17w ago | 8-K | $40.26 $40.63 | ▲ +0.92% | ▲ +2.22% | $41.22 (+2.38%) |
May 7, 2026 21w ago | 8-K | $35.58 $36.21 | ▲ +1.77% | ▼ −1.37% | $41.22 (+15.85%) |
Apr 23, 2026 23w ago | DEFA14A | $31.58 $32.69 | ▲ +3.51% | ▼ −0.51% | $41.22 (+30.53%) |
Mar 27, 2026 26w ago | 144 | $30.28 $30.99 | ▲ +2.34% | ▼ −10.25% | $41.22 (+36.13%) |
Feb 26, 2026 31w ago | 8-K | $29.66 $31.65 | ▲ +6.71% | ▲ +13.11% | $41.22 (+38.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access